Catalent Xpress Pharmaceutics™
Please log in for more information
The Xpress Pharmaceutics™ service has been designed to accelerate development of oral drugs through Phase 1 clinical studies. By integrating formulation development, on-demand clinical manufacturing, regulatory support and clinical testing, the approach can reduce both the cost and time taken to complete first-in-human trials.
Xpress Pharmaceutics allows Catalent to work alongside innovator and clinical research organizations, and provide formulated clinical trial material in line with adaptive study protocols, providing a faster alternative to traditional clinical development models, and offering the advantage of flexible dose and/or formulation composition adjustment during a clinical trial, guided by real-time clinical data.
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products.
With more than 85 years’ experience across prescription and consumer markets, Catalent has the deepest expertise, the broadest offerings, and the most innovative technologies, to help its customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and supply.
From a single, tailored solution, to multiple answers throughout a product’s lifecycle, Catalent can improve the total value of treatments, and accelerate programs to clinic and beyond.
